Production (Stage)
Arcutis Biotherapeutics, Inc.
ARQT
$13.98
$0.322.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 198.09M | 227.96M | 330.56M | 362.44M | 403.87M |
| Total Receivables | 85.42M | 73.07M | 60.12M | 43.41M | 37.15M |
| Inventory | 16.61M | 14.53M | 14.02M | 13.88M | 13.25M |
| Prepaid Expenses | 16.01M | 12.29M | 9.47M | 11.71M | 13.18M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.54M | 7.99M | 9.55M | 3.15M | 617.00K |
| Total Current Assets | 323.67M | 335.82M | 423.72M | 434.59M | 468.06M |
|
|
|||||
| Total Current Assets | 323.67M | 335.82M | 423.72M | 434.59M | 468.06M |
| Net Property, Plant & Equipment | 3.34M | 2.99M | 3.25M | 3.51M | 3.63M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 16.50M | 9.48M | 9.79M | 6.06M | 6.25M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 596.00K | 596.00K | 596.00K | 595.00K | 596.00K |
| Total Assets | 344.11M | 348.89M | 437.35M | 444.76M | 478.54M |
|
|
|||||
| Total Accounts Payable | 24.53M | 14.22M | 19.33M | 7.94M | 12.97M |
| Total Accrued Expenses | 65.76M | 65.97M | 52.79M | 42.63M | 33.58M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 842.00K | 820.00K | 100.31M | 777.00K | 756.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 91.13M | 81.01M | 172.43M | 51.35M | 47.31M |
|
|
|||||
| Total Current Liabilities | 91.13M | 81.01M | 172.43M | 51.35M | 47.31M |
| Long-Term Debt | 107.62M | 107.20M | 105.10M | 203.81M | 202.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.34M | 2.56M | 2.77M | 2.98M | 3.18M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 360.00K | 570.00K | 420.00K | 194.00K | 306.00K |
| Total Liabilities | 201.45M | 191.35M | 280.71M | 258.33M | 253.60M |
|
|
|||||
| Common Stock & APIC | 1.29B | 1.28B | 1.27B | 1.26B | 1.24B |
| Retained Earnings | -1.15B | -1.12B | -1.11B | -1.07B | -1.02B |
| Treasury Stock & Other | -140.00K | -7.00K | 533.00K | -294.00K | -133.00K |
| Total Common Equity | 142.66M | 157.54M | 156.64M | 186.43M | 224.94M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 142.66M | 157.54M | 156.64M | 186.43M | 224.94M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 142.66M | 157.54M | 156.64M | 186.43M | 224.94M |
|
|
|||||